Back to today’s briefing

Story perspectives

Revolutionary Genetic Test Offers Hope for Rare Diseases

1/16/2025

41 6

Summary

Story summary

A groundbreaking test from Belgium's Leuven Centre for Human Genetics harnesses nanopore sequencing to identify genetic and epigenetic abnormalities. This innovative approach not only accelerates diagnoses for rare diseases but also offers hope to hundreds of patients each month, paving the way for a more affordable and comprehensive standard in diagnosing unexplained developmental disorders.

1 of 1

Story summary

A groundbreaking test from Belgium's Leuven Centre for Human Genetics harnesses nanopore sequencing to identify genetic and epigenetic abnormalities. This innovative approach not only accelerates diagnoses for rare diseases but also offers hope to hundreds of patients each month, paving the way for a more affordable and comprehensive standard in diagnosing unexplained developmental disorders.